
Mesoblast (ASX:MSB) is an Australian cell therapy company focused on the development and commercialization of cell therapy products for a range of diseases. The company's operations are focused on the manufacturing of cell therapy products, clinical trials of cell therapy products, regulatory approval of cell therapy products, and commercialisation of cell therapy products. Mesoblast's objective is to become a leading cell therapy company in the world.